• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 339-353 of 901 results

1061 Exhibit: US Patent App Pub No 20110166321

Document IPR2024-00009, No. 1061 Exhibit - US Patent App Pub No 20110166321 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1033 Exhibit: Knudsen, Liraglutide, Analogue Based Drug Fischer Ganellin 2010

Document IPR2024-00009, No. 1033 Exhibit - Knudsen, Liraglutide, Analogue Based Drug Fischer Ganellin 2010 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1070 Exhibit: Boylan, Parenteral Products, Gilbert S Banker et al eds, 3d ed 1996

Document IPR2024-00009, No. 1070 Exhibit - Boylan, Parenteral Products, Gilbert S Banker et al eds, 3d ed 1996 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1021 Exhibit: Byetta prescribing information Oct 2009

Document IPR2024-00009, No. 1021 Exhibit - Byetta prescribing information Oct 2009 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1032 Exhibit: Knudsen, Glucagon like Peptide 1, 47 J MED CHEMISTRY 4128 2004

Document IPR2024-00009, No. 1032 Exhibit - Knudsen, Glucagon like Peptide 1, 47 J MED CHEMISTRY 4128 2004 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1040 Exhibit: Vilsbøll, Glucagon Like Peptide 1, INT’L DIABETES MONITOR 1 2009

Document IPR2024-00009, No. 1040 Exhibit - Vilsbøll, Glucagon Like Peptide 1, INT’L DIABETES MONITOR 1 2009 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1026 Exhibit: HARRISON’S PRINCIPLES OF INTERNAL MED, 338 Fauci 17th eds 2...

Document IPR2024-00009, No. 1026 Exhibit - HARRISON’S PRINCIPLES OF INTERNAL MED, 338 Fauci 17th eds 2008 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1087 Exhibit: Prosecution history excerpts for US Patent No 9,764,003

Document IPR2024-00009, No. 1087 Exhibit - Prosecution history excerpts for US Patent No 9,764,003 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1011 Exhibit: WO 2011138421

Document IPR2024-00009, No. 1011 Exhibit - WO 2011138421 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1056 Exhibit: US Patent No 5,118,666

Document IPR2024-00009, No. 1056 Exhibit - US Patent No 5,118,666 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1071 Exhibit: US Patent No 6,284,727

Document IPR2024-00009, No. 1071 Exhibit - US Patent No 6,284,727 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1077 Exhibit: Award ClinicalTrialsgov

Document IPR2024-00009, No. 1077 Exhibit - Award ClinicalTrialsgov (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1084 Exhibit: EMA, ICH Topic S 7 A Safety Pharma Studies for Human Pharma Jun...

Document IPR2024-00009, No. 1084 Exhibit - EMA, ICH Topic S 7 A Safety Pharma Studies for Human Pharma June 2001 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1055 Exhibit: Landersdorfer, Mechanism Based 73 BRIT J CLINICAL PHARMACOL...

Document IPR2024-00009, No. 1055 Exhibit - Landersdorfer, Mechanism Based 73 BRIT J CLINICAL PHARMACOLOGY 373 2011 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1048 Exhibit: FDA Guidance for Industry, Analysis, and Regulatory Applns Apr 200...

Document IPR2024-00009, No. 1048 Exhibit - FDA Guidance for Industry, Analysis, and Regulatory Applns Apr 2003 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 23 24 25 26 27 ... >>